FDA inspection
Ardelyx, Inc.: FDA inspection ending Jul 24, 2023
FDA inspection 1210671 · Voluntary Action Indicated (VAI) · Fremont, CA
Key facts
| Inspection ID | 1210671 |
|---|---|
| Firm | Ardelyx, Inc. |
| FEI number | 3010169178 |
| Address | 34175 Ardenwood Blvd Ste 200 |
| City | Fremont |
| State | CA |
| ZIP | 94555 |
| Country | United States |
| Fiscal year | 2023 |
| Inspection end date | Jul 24, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data